Finally, we show that HDAC3 KO in BMSC impairs tumor engraftment and growth in a murine xenograft model of human MM, further supporting the potential clinical utility of HDAC3 inhibition to target MM cells in the context of the BM niche. Here, HDAC3 is linked to neoplasm.